Format

Send to

Choose Destination
See comment in PubMed Commons below
Obesity (Silver Spring). 2014 Mar;22(3):882-7. doi: 10.1002/oby.20527. Epub 2013 Aug 23.

Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program.

Author information

1
Departments of Medicine and Obstetrics & Gynecology, University of Michigan, Ann Arbor, Michigan, USA.

Abstract

OBJECTIVES:

To examine whether estrogen use potentiates weight loss interventions via sex steroid levels and whether endogenous sex steroid levels predict response to weight loss interventions among women not using estrogen.

METHODS:

The Diabetes Prevention Program randomized overweight or obese dysglycemic participants to lifestyle change with the goals of weight reduction of >7% of initial weight and 150 minutes per week of exercise, metformin, or placebo. In this secondary analysis, we examined sex steroid levels and reductions in weight and waist circumference (WC) among postmenopausal women using (n = 324) and not using (n = 382) oral estrogen.

RESULTS:

Estrogen users and nonusers randomized to lifestyle change and metformin both lost significant amounts of weight compared to placebo. Reductions in weight and WC over 1 year associated with randomization arm were not associated with baseline sex steroid levels among estrogen users or nonusers.

CONCLUSIONS:

Among estrogen users, baseline sex steroids were not associated with reductions in weight or WC, suggesting that exogenous estrogen does not potentiate weight loss by altering sex steroids. Among nonestrogen users, baseline sex steroids were not associated with reductions in weight or WC.

PMID:
23804582
PMCID:
PMC3818475
DOI:
10.1002/oby.20527
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center